Research and treatment approaches to depression
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Depression is a major cause of disability worldwide, but we know little about the underlying fundamental biology. Research is hindered by the difficulties of modelling a disorder of higher cognitive functions in animals. Depression can be understood as the interaction of genetic susceptibility and environmental factors; however, current classifications are purely descriptive. The complexity of this field is best approached by rigorous explorations of known candidate systems in conjunction with the use of genomic tools to discover new targets for antidepressants and to predict therapeutic outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies using PET imaging 87 as well as analyses of post-mortem brain tissue 88 have indicated neuroinflammation and microglial activation in the central nervous systems of patients with MDD.”
From Major depressive disorder (2016) · cites this paper as [87]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Learned helplessness in humans: Critique and reformulation.
Abramson, L. Y., Seligman, M. E., & Teasdale, J. D. (1978) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.87.1.49 · Cited by 7,121
(1996) · Cited by 6,884
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 1×
“have identified a functional polymorphism in the upstream regulatory region of the serotonin transporter gene that affects transcriptional efficienc”
BackgroundA Syndrome produced by Diverse Nocuous Agents
SELYE, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,903
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431 · cited 1×
“Major depression has an estimated heritability of 31–42%, which is much lower than the 70% heritability estimated for schizophrenia and bipolar disorde”
BackgroundGenetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,413
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302 · cited 1×
“A detailed and well-controlled cross-national epidemiological study examined lifetime rates of depression in ten countrie”
BackgroundExcess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“Depressed patients have an increased risk of premature death when compared with control subject”
Background
Research works printed but not linked: 1
- Nobel Foundation. Nobel Lectures — Physiology or Medicine, 1901–1970 (Elsevier, Amsterdam, 1970).
Cited by
Items 201–300 of 674
Kushwah, N., Jain, V., Deep, S., Prasad, D. N., Singh, S. B., & Khan, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149309 · Cited by 62
RetractedDepressive-like behavior induced by tumor necrosis factor-α is abolished by agmatine administration
Neis, V. B., Manosso, L. M., Moretti, M., Freitas, A. E., Daufenbach, J., & Rodrigues, A. L. S. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.038 · Cited by 59
Long, H., Liu, B., Hou, B., Wang, C., Li, J., Qin, W., Wang, D., Zhou, Y., Kendrick, K. M., Yu, C., et al. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1299-x · Cited by 62
Ferrés-Coy, A., Galofré, M., Pilar-Cuéllar, F., Vidal, R., Paz, V, Ruiz-Bronchal, E., Campa, L., Pazos, Á., Caso, J. R., Leza, J. C., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.80 · Cited by 57
Moretti, M., Budni, J., Freitas, A. E., Neis, V. B., Ribeiro, C. M., Balen, G. O., Rieger, D. K., Leal, R. B., & Rodrigues, A. L. S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.006 · Cited by 58
Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor
Xue, R., Jin, Z., Chen, H., Li, Y., He, X., Zhang, Y., Meng, Y., Xu, J., Zheng, J., Zhong, B., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.001 · Cited by 59
“Major depressive disorder (MDD) is a common and severe psychiatric disorder with a lifetime prevalence of 10–20% (Wong and Licinio, 2001).”
BackgroundWong, M.-L., O'Kirwan, F., HANNESTAD, J., Irizarry, K. J. L., Elashoff, D. A., & Licinio, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001470 · Cited by 63
Self-citationHolmes, A. J., Bogdan, R., & Pizzagalli, D. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.223 · Cited by 57
“Both genetic and environmental factors are implicated in the etiology of major depressive disorder (MDD; Wong and Licinio, 2001).”
Antidepressant-Like Effects of Sarsasapogenin from Anemarrhena asphodeloides BUNGE (Liliaceae)
Ren, L., Luo, Y., Li, X., Zuo, D., & Wu, Y. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.2304 · Cited by 57
Huang, X., Wu, H., Jiang, R., Sun, G., Shen, J., Ma, M., Ma, C., Zhang, S., Huang, Z., Wu, Q., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.020 · Cited by 61
Torres-Vega, A., Pliego‐Rivero, B., Otero, G., Gómez‐Oliván, L. M., & Vieyra-Reyes, P. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00521.x · Cited by 58
Molecular epidemiology of major depressive disorder
Kiyohara, C., & Yoshimasu, K. (2009) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-008-0073-6 · Cited by 53
“Environmental factors, such as prenatal factors, loss, deprivation, grief, stress, natural disasters, war, social support systems, nutrition, exercise, drug effects, and medical illness, have been linked to major depressive disorder [19].”
BackgroundThompson, B. J., Jessen, T. N., Henry, L. K., Field, J. R., Gamble, K. L., Gresch, P. J., Carneiro, A. M. D., Horton, R. E., Chisnell, P. J., Belova, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011920108 · Cited by 63
“Although SERTblockade occurs within minutes of administration, antidepressant efficacy arises only after many weeks of treatment (6), leading some to question whether SERT inhibition is responsible for the beneficial actions of SSRIs.”
BackgroundBiological substrates underpinning diagnosis of major depression
Sibille, E., & French, B. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000436 · Cited by 50
“2b), displaying moderate efficacy for a range of psychiatric and systemic disorders (Wong and Licinio, 2001; Warden et al., 2007).”
BackgroundAcute effects of ayahuasca in a juvenile non-human primate model of depression
da Silva, F. S., Silva, E. A. S., Sousa Jr., G. M. D., Maia-de-Oliveira, J. P., Soares-Rachetti, V. D. P., de Araujo, D. B., Sousa, M. B. C., Lobão-Soares, B., Hallak, J., & Galvão-Coelho, N. L. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0140 · Cited by 46
Open space swimming test to index antidepressant activity
Sun, M., & Alkon, D. L. (2003) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(03)00068-2 · Cited by 55
Lim, C.-S., Hoang, E. T., Viar, K. E., Stornetta, R. L., Scott, M. M., & Zhu, J. J. (2014) · Genes & Development · doi:10.1101/gad.232470.113 · Cited by 56
“…and often involved in neuronal signaling regulation; many of these proteins belong to the NMDA-R–Ras–PI3K/PKB signaling interactome, including several Ras-binding partners, activators, and inactivators (Zhong et al. 1999; Brown et al. 2001; Zalfa et al. 2003; Luo et al. 2010; Darnell et al. 2011).”
BackgroundModeling of the Temporal Patterns of Fluoxetine Prescriptions and Suicide Rates in the United States
Milane, M. S., Suchard, M. A., Wong, M.-L., & Licinio, J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030190 · Cited by 49
“The point prevalence is in the range of 3% (2% in men, 4% in women) [5,6], but increases up to 10% in the elderly [7,8].”
BackgroundSelf-citationChen, S.-J., Kao, C.-L., Chang, Y.-L., Yen, C.-J., Shui, J.-W., Chien, C.-S., Chen, I.-L., Tsai, T.-H., Ku, H.-H., & Chiou, S.-H. (2007) · Current Neurovascular Research · doi:10.2174/156720207779940707 · Cited by 56
“1567-2026/07 $50.00+.00 ©2007 Bentham Science Publishers Ltd. Previous studies demonstrated that stress-induced loss of hippocampal neurons may contribute to the pathogenesis of depression.”
BackgroundInfluentialAntidepressant activity of methanolic extract of amaranthus spinosus.
Kumar, B. S. A., Lakshman, K., Velmurugan, C., Sridhar, S., & Saran, G. S. (2014) · PubMed Central · Cited by 84
Ferrés-Coy, A., Pilar-Cuellar, F., Vidal, R., Paz, V, Masana, M., Cortés, R., Carmona, M. C., Campa, L., Pazos, Á., Montefeltro, A., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.135 · Cited by 51
Carlini, V. P., Machado, D. G., Buteler, F., Ghersi, M., Ponzio, M. F., Martini, A. C., Schiöth, H. B., de Cúneo, M. F., Rodrigues, A. L. S., & de Barioglio, S. R. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.031 · Cited by 57
“Taking into account that there are few studies that report behavioral changes induced by OB in females and that depression is more prevalent in women than in men [50], this study was carried out in female mice.”
BackgroundGlia as a putative target for antidepressant treatments
Manev, H., Uz, T., & Manev, R. M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00044-7 · Cited by 55
Postolache, T. T., Lapidus, M., Sander, E. R., Langenberg, P., Hamilton, R. G., Soriano, J. J., McDonald, J. S., Furst, N., Bai, J., Scrandis, D. A., et al. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.286 · Cited by 51
“Increases in activity of TH1 cytokines, such as TNF-α have been shown to trigger depressivelike behaviors in experimental animal models [26-30] as well as decompensation of depression in humans[31].”
Gundersen, B. B., Briand, L. A., Onksen, J. L., Lay, J. E. L., Kaestner, K. H., & Blendy, J. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1669-13.2013 · Cited by 55
“The mechanism by which the initial pharmacological action of antidepressants, increasing synaptic levels of monoamine neurotransmitters (Frazer, 1997), translates into their much slower onset of therapeutic efficacy is not fully understood (Wong and Licinio, 2001; Nestler et al., 2002).”
BackgroundCohen-Woods, S., Gaysina, D., Craddock, N., Farmer, A., Gray, J., Gunasinghe, C., Hoda, F., Jones, L., Knight, J., Korszun, A., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp051 · Cited by 53
“The World Health Organisation suggests that as a leading cause of disability in adults, major depressive disorder (MDD) closely follows cardiovascular disease (1), but the pathogenesis and underlying aetiology of the disorder remain unclear (2).”
BackgroundIto, N., Nagai, T., Yabe, T., Nunome, S., Hanawa, T., & Yamada, H. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.01.002 · Cited by 54
“The incidence of human depression is worldwide, with a prevalence of 4–16% in some developed countries (Wong and Licinio, 2001).”
BackgroundLi, L., Sun, H., Ding, J., Niu, C., Su, M., Zhang, L., Li, Y., Wang, C., Gamper, N., Du, X., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14026 · Cited by 51
“Current treatments available for major depression are unsatisfactory due to their many side effects and low efficacy, leaving more than one-third of depressed individuals resistant to drug treatments (Wong and Licinio, 2001).”
BackgroundFactors producing a menopausal depressive-like state in mice following ovariectomy
Bekku, N., Yoshimura, H., & Araki, H. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0395-2 · Cited by 53
“Because genetic factors and gender differences in animals (for reviews, see Barros and Ferigolo 1998; Urani et al. 2005) and in humans (for reviews, see Wong and Licinio 2001; Sloan and Kornstein 2003) are involved in either the manifestation of depression or the susceptibility to antidepressants, there is a possibili…”
BackgroundGhisleni, G., Kazlauckas, V., Both, F. L., Pagnussat, N., Mioranzza, S., da Rocha, J. B. T., Souza, D. O., & Porciúncula, L. O. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.008 · Cited by 51
“On the other hand, abnormalities in 5HT neurotransmission have been implicated in the etiology of several psychiatric and neurological disorders as previously described to depression, anxiety and mood (Hoyer et al., 2002;Wong and Licinio, 2001).”
Chenu, F., Guiard, B. P., Bourin, M., & Gardier, A. M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.011 · Cited by 51
“Furthermore, about one third of these patients show only partial or no response to the treatment [56].”
BackgroundGenetic association study of individual symptoms in depression
Myung, W., Song, J., Lim, S., Won, H., Kim, S., Lee, Y., Kang, H. S., Lee, H., Kim, J., Carroll, B. J., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.037 · Cited by 53
“However, putative neural circuits in the pathophysiology of depression, as well as the pharmacodynamic mechanisms of antidepressant drugs can suggest initial strategies for study (Wong and Licinio, 2001).”
BackgroundChen, W., Xie, B., Zhang, C., Xu, K.-L., Niu, Y., Tang, X., Zhang, P., Zou, W., Hu, B., & Tian, Y. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283654258 · Cited by 50
“…current available antidepressants, including monoamine oxidase inhibitors and serotonin and/or norepinephrine selective reuptake inhibitors, and a period of weeks to months of continuous treatment is usually required for a full therapeutic response (Wong and Licinio, 2001; Cassano and Fava, 2004).”
BackgroundSuzuki, M., Furihata, R., Konno, C., Kaneita, Y., Ohida, T., & Uchiyama, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.024 · Cited by 52
Neis, V. B., Bettio, L. E. B., Moretti, M., da Rosa, P. B., Ribeiro, C. M., Freitas, A. E., Gonçalves, F. M., Leal, R. B., & Rodrigues, A. L. S. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.10.004 · Cited by 54
Piato, Â., Detanico, B. C., Jesus, J. F., Lhullier, F. L. R., Nunes, D. S., & Elisabetsky, E. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.04.018 · Cited by 55
Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells
Baik, S.-Y., Jung, K. H., Choi, M., Yang, B., Kim, S. H., Lee, J., Oh, D.-Y., Choi, I.-G., Chung, H., & Chai, Y. G. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.047 · Cited by 47
Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose
Viglione, A., Chiarotti, F., Poggini, S., Giuliani, A., & Branchi, I. (2019) · The Pharmacogenomics Journal · doi:10.1038/s41397-019-0080-6 · Cited by 48
Zhao, Z., Baros, A. M., Zhang, H., Bluhm, M. D. L., Bondi, C. O., Morilak, D. A., & O’Donnell, J. M. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.45 · Cited by 53
Antidepressant-like effect of creatine in mice involves dopaminergic activation
Cunha, M. P., Machado, D. G., Capra, J. C., Jacinto, J., Bettio, L. E., & Rodrigues, A. L. S. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112447989 · Cited by 42
“Depression is a common mood disorder associated with high rates of morbidity and mortality and with a lifetime prevalence of around 17% (Wong and Licinio, 2001).”
BackgroundZiziphi spinosae lily powder suspension in the treatment of depression-like behaviors in rats
Wang, Y., Huang, M., Lü, X., Wei, R., & Xu, J. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1749-5 · Cited by 47
“Although many antidepressant drugs have been developed, treatments with those drugs are not always satisfactory [33, 34].”
BackgroundAltered protein kinase a in brain of learned helpless rats: effects of acute and repeated stress
Dwivedi, Y., Mondal, A. C., Shukla, P. K., Rizavi, H. S., & Lyons, J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.018 · Cited by 46
Huang, Z., Huang, X., Wang, Q., Jiang, R., Sun, G., Xu, Y., & Wu, Q. (2018) · IUBMB Life · doi:10.1002/iub.1731 · Cited by 49
“Depression is one of the most debilitating mental disorders worldwide, and places a heavy emotional and economic burden on both patients and their families (1,2).”
BackgroundBusnello, J. V., Leke, R., Oses, J. P., Feier, G., Brüch, R. S., Quevedo, J., Kapczinski, F. P., Souza, D. O., & Portela, L. V. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.11.028 · Cited by 44
Association between depression and epigenetic age acceleration: A co‐twin control study
Liu, C., Wang, Z., Hui, Q., Goldberg, J. H., Smith, N. L., Shah, A. J., Murrah, N. V., Shallenberger, L. H., Diggers, E., Bremner, J. D., et al. (2022) · Depression and Anxiety · doi:10.1002/da.23279 · Cited by 44
“Worldwide, depression is currently affecting 350 million people (Smith, 2014), with common clinical symptoms such as fatigue, depressed mood, pessimism, low self‐esteem, and suicide ideation (Wong & Licinio, 2001).”
BackgroundAntidepressant-like activity of plumbagin in unstressed and stressed mice
Dhingra, D., & Bansal, S. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.001 · Cited by 46
Wong, M., Dong, C., Flores, D. L., Ehrhart‐Bornstein, M., Bornstein, S. R., Arcos‐Burgos, M., & Licinio, J. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.12091165 · Cited by 43
Self-citationXi, G., Zhang, X., Zhang, L., Sui, Y., Hui, J., Liu, S., Wang, Y., Li, L., & Zhang, Z. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2077-3 · Cited by 44
“The primary action of SSRI is based on the inhibition of serotonin reuptake and the elevation of the synaptic monoamines serotonin [5-hydroxytryptamine (5-HT)]; however, although the extracellular 5-HT is rapidly increased, the therapeutic effects usually take several weeks to develop fully (Wong and Licinio 2001).”
BackgroundThe evolution of deep brain stimulation for neuropsychiatric disorders
Greenberg, B. (2008) · Frontiers in Bioscience · doi:10.2741/3029 · Cited by 42
Stellate ganglion block attenuates chronic stress induced depression in rats
Wang, W., Shi, W., Qian, H., Deng, X., Wang, T., & Li, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183995 · Cited by 42
Szczepanik, J. C., de Almeida, G. R. L., Cunha, M. P., & Dafré, A. L. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02921-2 · Cited by 45
Li, B., Wang, Y., Gao, D., Ren, S., Li, L., Li, N., An, H., Zhu, T., Yang, Y., Zhang, H., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010757 · Cited by 41
Therapeutic potential of plant iridoids in depression: a review
Kou, Y., Li, Z., Yang, T., Shen, X., Wang, X., Li, H., Zhou, K., Li, L., Xia, Z., Zheng, X., et al. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2136206 · Cited by 44
“It is now believed that alterations in brain gene expression that are elicited after chronic treatment might underlie the effects of antidepressants (Wong and Licinio 2001).”
BackgroundCunha, M. P., Pazini, F. L., Oliveira‐Giacomelli, Á., Machado, D. G., & Rodrigues, A. L. S. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.01.005 · Cited by 45
Cui, Y., Huang, X., Huang, P., Huang, L., Feng, Z., Xiang, X., Chen, X., Li, A., Ren, C., & Li, H. (2022) · Science Advances · doi:10.1126/sciadv.abn0193 · Cited by 41
Molecular fMRI of Serotonin Transport
Hai, A., Cai, L. X., Lee, T., Lelyveld, V. S., & Jasanoff, A. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.048 · Cited by 45
“A particularly well-known example is the use of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depression (Vaswani et al., 2003; Wong and Licinio, 2001).”
Patrício, P., Mateus-Pinheiro, A., Sousa, N., & Pinto, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8422-x · Cited by 38
“The main support of this hypothesis is the fact that most classic antidepressants induce an increase of the serotonin and noradrenaline levels [103].”
BackgroundZomkowski, A. D. E., Engel, D. F., Cunha, M. P., Gabilan, N. H., & Rodrigues, A. L. S. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.011 · Cited by 43
The Promises and Pitfalls of Reboxetine
Page, M. E. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00258.x · Cited by 47
“The prevalence rate of depression has been reported to be as high as 17% (110).”
BackgroundPinnock, S. B., Lazic, S. E., Wong, H. T., Wong, I., & Herbert, J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.035 · Cited by 42
Ito, N., Yabe, T., Nagai, T., Oikawa, T., Yamada, H., & Hanawa, T. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1716 · Cited by 40
Genetic Approaches to Modeling Anxiety in Animals
Jacobson, L. H., & Cryan, J. F. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_31 · Cited by 41
Allaman, I., Papp, M., Kraftsik, R., Fiumelli, H., Magistretti, P. J., & Martin, J. (2008) · PubMed · Cited by 44
Carlini, V. P., Poretti, M. B., Rask-Andersen, M., Chavan, R. A., Ponzio, M. F., Sawant, R. S., de Barioglio, S. R., Schiöth, H. B., & de Cuneo, M. F. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.03.004 · Cited by 39
“Serotonin-specific reuptake inhibitors (SSRI) and serotoninnorepinephrine reuptake inhibitors (SNRI) are antidepressant drugs commonly used to treat a wide spectrum of mood disorders (Wong and Licinio, 2001).”
BackgroundKnapman, A., Heinzmann, J.-M., Holsboer, F., Landgraf, R., & Touma, C. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.04.010 · Cited by 41
“Although many treatment strategies are available, major depression (MD) is not a fully treatable disorder (Holsboer & Ising, 2010; Wong & Licinio, 2001).”
BackgroundDjillani, A., Piétri, M., Moréno, S., Heurteaux, C., Mazella, J., & Borsotto, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00643 · Cited by 39
“Depression is the most devastating and common mood disorder (Wong and Licinio, 2001).”
BackgroundIncreased depressive-like traits in an animal model of premenstrual irritability
Schneider, T., & Popik, P. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.09.006 · Cited by 40
Brüning, C. A., Prigol, M., Roehrs, J. A., Nogueira, C. W., & Zeni, G. R. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.08.010 · Cited by 39
Kuhn, M., Weidenauer, A., & Pezawas, L. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139005 · Cited by 45
“Apart from that, MDD is undoubtedly heritable, given the known accumulation of cases in families (Kupfer et al., 2012; Wong & Licinio, 2001).”
BackgroundWang, D., Wang, W., Jiang, S., Ma, H., Lian, H., Meng, F., Liu, J., Cui, M., You, J., Liu, C., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.043 · Cited by 41
Ettaoussi, M., Sabaouni, A., Rami, M., Boutin, J. A., Delagrange, P., Renard, P., Spedding, M., Caignard, D., Berthelot, P., & Yous, S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.027 · Cited by 42
Effects of pre-germinated brown rice on depression-like behavior in mice
Mamiya, T., Kise, M., Morikawa, K., Aoto, H., Ukai, M., & Noda, Y. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.008 · Cited by 47
Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs
Tardito, D., Mallei, A., & Popoli, M. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.749237 · Cited by 35
“MD are complex disorders whose pathogenesis is still essentially unknown, with about 30 -- 40% of heritability in populationbased samples [19], and it is currently accepted that genetic predisposing factors, such as DNA sequence polymorphisms that confer individual vulnerability, and environmental factors concur in th…”
BackgroundFreitas, A. E., Bettio, L. E. B., Neis, V. B., Moretti, M., Ribeiro, C. M., Lopes, M. W., Leal, R. B., & Rodrigues, A. L. S. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.024 · Cited by 38
“In the present study, female mice were chosen because more women than men suffer depression (Wong and Licinio, 2001).”
BackgroundZhang, Y.-J., Huang, W., Huang, X., Wang, Y., Wang, Z., Wang, C., Zhong, B., Sheng, C., Wang, B., Zhang, S.-F., et al. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.05.015 · Cited by 35
Hua, Y., Huang, X., Zhou, L., Zhou, Q., Hu, Y. F., Luo, C., Li, F. Y., & Zhu, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1200-1 · Cited by 41
“Major depression is a serious mental disorder, with a lifetime risk of 10–20% ( Wong and Licinio 2001 ).”
BackgroundThe therapeutic potentials of Ayahuasca in the treatment of depression
Palhano-Fontes, F., Alchieri, J. C., Oliveira, J. P. M., Soares, B. L., Hallak, J. E. C., Galvao-Coelho, N., & de Araujo, D. B. (2014) · The Therapeutic Use of Ayahuasca · doi:10.1007/978-3-642-40426-9_2 · Cited by 36
“nephrine, and serotonin (Wong and Licinio 2001).”
Cambiaghi, M., Crupi, R., Bautista, E. L., Elsamadisi, A., Malik, W., Pozdniakova, H., Han, Z., Buffelli, M., & Battaglia, F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17114074 · Cited by 39
Cristóbal-Narváez, P., Haro, J. M., & Koyanagi, A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.041 · Cited by 40
Diers, J. A., Ivey, K., El‐Alfy, A. T., Shaikh, J., Wang, J., Kochanowska-Karamyan, A. J., Stoker, J. F., Hamann, M. T., & Matsumoto, R. R. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.10.021 · Cited by 41
“Depression is a particularly debilitating neuropsychiatric disorder that affects about 20% of the total population of the United States (Wong and Lichinio, 2001; Nestler et al., 2002; Society for Neuroscience, 2002; Matthews et al., 2005).”
BackgroundLiu, X., Liu, F., Yue, R., Li, Y., Zhang, J., Wang, S., Zhang, S., Wang, R., Shan, L., & Zhang, W. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.007 · Cited by 37
“Although commercially available antidepressant drugs are effective, treatment with those drugs is often accompanied by undesirable side effects and a certain proportion of patients with depression have a limited response to the therapeutic effects of these drugs (Krishnan and Nestler, 2008; Wong and Licinio, 2001).”
BackgroundLiu, Q., Yu, J. M., Mao-Ying, Q.-L., Mi, W.-L., Li, B., Yq, W., Wang, J., & Wu, G. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500485 · Cited by 38
“Despite a number of preclinical and clinical investigations, little is known about the etiology of depression and the mechanisms responsible for the therapeutic effects of antidepressant drugs”
BackgroundJessé, C. R., Wilhelm, E. A., Bortolatto, C. F., & Nogueira, C. W. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.023 · Cited by 36
“The clinical therapy of depression is based on classical antidepressant drugs such as monoamine oxidase inhibitors (MAOi; e.g. tranylcypromine), catecholamine reuptake inhibitors (e.g. imipramine), and selective inhibitors of serotonin reuptake (SSRIs; e.g. fluoxetine) (Wong and Licinio, 2001).”
BackgroundShaping therapeutic trajectories in mental health: Instructive vs. permissive causality
Branchi, I., & Giuliani, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.12.001 · Cited by 37
Ventura-Juncá, R., Symon, A., López, P., Fiedler, J. L., Rojas, G., Heskia, C., Lara, P., Marín, F., Guajardo, V., Araya, A. V., et al. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0220-0 · Cited by 34
“Intriguingly, the therapeutic response is observed with a delay of several weeks after the initiation of treatment [7].”
Huang, Y.-F., Yang, C., Huang, C., & Hsu, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.392076 · Cited by 36
“Co-transfection of antagomiR-107 with shRNA-HIF-1 suppressed antagomiR-107-induced increase in spine number (F(1,91) 0.”
BackgroundMethodInfluentialPlasticity in mental health: A network theory
Branchi, I. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104691 · Cited by 35
S100A10 and its binding partners in depression and antidepressant actions
Chen, M. X., Oh, Y., & Kim, Y. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.953066 · Cited by 35
“Future studies should identify actual molecular changes of p11 and its pathways in these new cell types with animal models of depression and brain tissues from MDD patients.”
BackgroundInfluentialThe Role of the HPA Axis in Psychiatric Disorders and CRF Antagonists as Potential Treatments
Keller, P. A., McCluskey, A., Morgan, J., & O'Connor, S. M. J. (2006) · Archiv der Pharmazie · doi:10.1002/ardp.200600021 · Cited by 40
Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system
Kusakawa, S., Yamauchi, J., Miyamoto, Y., Sanbe, A., & Tanoue, A. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.10.008 · Cited by 33
Yu, X., Dong, R., Wang, H., Lin, J., An, Y., Du, Y., Tang, S., Hu, M. Y., Long, Y., Sun, H., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4136-2 · Cited by 34
Garcia, A. N., Bezner, K. S., Depena, C., Yin, W., & Gore, A. C. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.11.011 · Cited by 35
“Depression and anxiety are twice as common inwomen than inmen (Wong and Licinio, 2001), and menopause is associated with increases in affective dysfunctions (Freeman et al.”
BackgroundOrrico‐Sánchez, A., Chausset‐Boissarie, L., de Sousa, R. A., Coutens, B., Amin, S. R., Vialou, V., Louis, F., Hessani, A., Dansette, P. M., Zornoza, T., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0548-4 · Cited by 33
“rationale for the enduring monoamine hypothesis, which stipulates that depression results from an imbalance in serotonin (5-hydroxytryptamine, 5-HT), norepinephrine (NE), and/or dopamine (DA) signaling in the brain, which may be restored by long-term antidepressant treatment [2].”
BackgroundMishra, P. K., Adusumilli, M., Deolal, P., Mason, G. F., Kumar, A., & Patel, A. B. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104750 · Cited by 34
Jin, Z., Gao, N., Zhang, J.-R., Li, X.-R., Chen, H., Xiong, J., Li, Y., & Tang, Y. C. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.013 · Cited by 33
Cabras, S., Saba, F., Reali, C., Scorciapino, L., Sirigu, A., Talani, G., Biggio, G., & Sogos, V. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000210 · Cited by 37
“However, in spite of a rapid increase in extracellular levels of these monoamines, therapeutic action of these drugs usually requires several weeks or months (Wong & Licinio, 2001).”
BackgroundExercise protects myelinated fibers of white matter in a rat model of depression
Xiao, Q., Wang, F., Luo, Y., Chen, L., Chao, F., Tan, C., Gao, Y., Huang, C., Zhang, L., Liang, X., et al. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24350 · Cited by 34
“…disorder with a lifetime prevalence of 10–20% worldwide (Berton & Nestler, 2006; Moussavi et al., 2007), ranks as the leading cause of disability globally due to its high morbidity, recurrence, and association with suicide (Krishnan & Nestler, 2008; Whiteford et al., 2013; Wong & Licinio, 2001).”
BackgroundScience and the spirit: a Pentecostal engagement with the sciences
(2011) · Choice Reviews Online · doi:10.5860/choice.48-4428 · Cited by 33
Umukoro, S., Adebesin, A., Agu, G., Omorogbe, O., & Asehinde, S. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.07.005 · Cited by 35
Liu, J., Li, Z., Liu, Y.-S., Chu, H.-D., Hu, N.-Y., Wu, D., Huang, L., Li, S.-J., Li, X., Yang, J., et al. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00474-x · Cited by 33
Metadata
- Authors
- Wong, M.-L., & Licinio, J.
- Affiliations
- University of California, Los Angeles (US)
- ORCID
- Wong, Ma-Li
- Venue
- Nature Reviews Neuroscience
- Published
- 2001-05
- Volume
- 2
- Issue
- 5
- Pages
- 343-351
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2102343823
- Cited by
- 656
- References
- 104
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 22 · 2020: 14 · 2019: 20 · 2018: 33 · 2017: 29 · 2016: 28 · 2015: 24 · 2014: 39 · 2013: 30 · 2012: 41
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, antidepressant targets, genetic susceptibility, environmental factors, animal models of depression, cognitive impairment, depression classification, genomic tools, therapeutic outcome prediction
- MeSH terms
- Animals, Antidepressive Agents, Brain Chemistry, Depression, Humans, Drug Design, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.